Dermatofibrosarcoma Protuberans

Dermatol Clin. 2019 Oct;37(4):483-488. doi: 10.1016/j.det.2019.05.006.

Abstract

Dermatofibrosarcoma protuberans (DFSP) is an uncommon dermal neoplasm that exhibits a high rate of local recurrence and infiltrative behavior, but has a low risk of metastasis. It arises as a slowly progressive, painless pink or violet plaque. Histologically, DFSP is characterized by a monomorphous spindle cell proliferation in a storiform pattern. The gold standard of treatment is surgical resection with negative margins. In cases where obtaining clear margins is not possible, radiation and systemic therapy with tyrosine kinase inhibitors, such as imatinib mesylate, has been shown to be effective.

Keywords: Cutaneous soft tissue sarcoma; Dermatofibrosarcoma protuberans; Fibrosarcomatous transformation; Imatinib mesylate; t(17;22) translocation.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Dermatofibrosarcoma / genetics
  • Dermatofibrosarcoma / pathology
  • Dermatofibrosarcoma / therapy*
  • Dermatologic Surgical Procedures
  • Humans
  • Imatinib Mesylate / therapeutic use
  • Margins of Excision
  • Mohs Surgery*
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / metabolism
  • Skin Neoplasms / genetics
  • Skin Neoplasms / pathology
  • Skin Neoplasms / therapy*
  • Translocation, Genetic / genetics

Substances

  • Antineoplastic Agents
  • COLIA1-PDGFB fusion protein, human
  • Oncogene Proteins, Fusion
  • Imatinib Mesylate